Drug-eluting stents may be as safe a choice as bare metal stents when followed by a blood thinning regimen tailored to individual patients, based on the results of a research letter published March 31 in the JAMA.

Updated recommendations for the treatment of nonvalvular atrial fibrillation now call for the use of radio frequency ablation as a treatment, a joint American Heart Association, American College of Cardiology and Heart Rhythm Society panel wrote in its 2014 guidelines issued March 28.

Although previous research suggested that metformin may preserve left ventricular ejection fraction (LVEF) after STEMI, research presented March 31 at the American College of Cardiology (ACC) scientific session in Washington, D.C., found metformin did not improve LVEF in post-STEMI nondiabetic patients after they underwent PCI.

Combining bariatric surgery with medical therapy for three years was more effective at glycemic control than medical therapy alone among obese patients with type 2 diabetes, according to research presented March 31 at the American College of Cardiology (ACC) scientific session in Washington, D.C.

Patients who receive clonidine during noncardiac surgery may have an increased risk of hypotension and nonfatal cardiac arrest, according to research presented March 31 at the American College of Cardiology (ACC) scientific session in Washington, D.C.

Pediatric interventional cardiologists may proceed with more confidence with bridge treatments for patients with congenital heart disease, based on a late-breaking clinical trial presented March 30 at the American College of Cardiology (ACC) scientific session in Washington, D.C. The post-approval analysis of a transcatheter valve gave it high marks in real-world practice.

Cardiac resynchronization therapy with a defibrillator (CRT-D) in patients with mild heart failure symptoms, left ventricular dysfunction and a left bundle branch block may improve survival, researchers found. They presented their late-breaking clinical trial data March 30 at the American College of Cardiology (ACC) scientific session in Washington, D.C. 

Darapladib did not significantly reduce the risk of cardiovascular death, MI or stroke associated with coronary heart disease, according to study results presented March 30 at the American College of Cardiology (ACC) scientific session in Washington, D.C.